Vitamin D Supplementation in Multiple Sclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT01490502

Recruitment Status : Recruiting

First Posted : December 13, 2011

Last Update Posted : September 29, 2017

See Contacts and Locations

Sponsor:

Collaborators:

Oregon Health and Science University

University of California, San Francisco

Washington University School of Medicine

Icahn School of Medicine at Mount Sinai

University of Pennsylvania

Yale University

The Cleveland Clinic

University of Rochester

Stanford University

University of Virginia

Swedish Medical Center

Anne Arundel Health System Research Institute

Columbia University

University of Massachusetts, Worcester

Dignity Health

Information provided by (Responsible Party):

Johns Hopkins University

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Recruiting
Estimated Primary Completion Date :	March 2019
Estimated Study Completion Date :	March 2019

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Bhargava P, Cassard S, Steele SU, Azevedo C, Pelletier D, Sugar EA, Waubant E, Mowry EM. The vitamin D to ameliorate multiple sclerosis (VIDAMS) trial: study design for a multicenter, randomized, double-blind controlled trial of vitamin D in multiple sclerosis. Contemp Clin Trials. 2014 Nov;39(2):288-93. doi: 10.1016/j.cct.2014.10.004. Epub 2014 Oct 12.

To Top